Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients

Journal of Clinical Virology

Volumn 56, Issue 2, 2013, Pages 124-128

  Boaretti, M ^a,b   Sorrentino, A ^b   Zantedeschi, C ^a   Forni, A ^a   Boschiero, L ^b   Fontana, R ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

CMV DNA; Cytomegalovirus; Real time PCR

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; ASSAY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST ACCURACY STUDY; DNA EXTRACTION; EARLY DIAGNOSIS; FEMALE; GRAFT RECIPIENT; HEART GRAFT; HUMAN; KIDNEY GRAFT; LABORATORY AUTOMATION; MALE; ORGAN TRANSPLANTATION; PP65 ANTIGENEMIA ASSAY; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROLOGY; VIRUS DETECTION; VIRUS LOAD;

ADULT; AGED; AUTOMATION; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TRANSPLANTATION; TRANSPLANTS; VIRAL LOAD; YOUNG ADULT;

EID: 84872370590     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.10.015     Document Type: Article

References (26)

1. Steininger C. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system. Clin Microbiol Infect 2007, 13(10):953-963.
2. Kotton C.N. Management of cytomegalovirus infection in solid organ transplantation. Nat Rev Nephrol 2010, 6:711-721.
3. Allice T., Cerutti F., Pittaluga F., Varetto S., Franchello A., Salizzoni M., et al. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65 test in guiding pre-emptive antiviral treatment. J Virol Methods 2008, 148(1-2):9-16.
4. Gerna G., Baldanti F., Lilleri D. Management of human cytomegalovirus infection in transplant recipients by the pre-emptive therapy approach. Future Virol 2009, 4(2):155-164.
5. Kusne S., Grossi P., Irish W., St George K., Rinaldo C., Rakela J., et al. Cytomegalovirus pp65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1999, 68(8):1125-1131.
6. Baldanti F., Lilleri D., Gerna G. Monitoring human cytomegalovirus infection in transplant recipients. J Clin Virol 2008, 41:237-241.
7. Kalpoe J.S., Kroes A.C.M., de Jong M.D., Schinkel J., de Brouwer C.S., Beersma M.F.C., Claas E.C.J. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 2004, 42:1498-1504.
8. Kotton C.N., Kumar D., Caliendo A.M., åsberg A., Chou S., Snydman D.R., et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2010, 89(7):779-795.
9. Gentile G., Picardi A., Capobianchi A., Spagnoli A., Cudillo L., Dentamaro T., et al. A prospective study comparing quantitative cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogenic stem cell transplantation. BMC Infect Dis 2006, 6:167.
10. Cariani E., Pollara C.P., Valloncini B., Peranin F., Bonfanti C., Manca N. Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for human cytomegalovirus (HCMV) management in immunocompromised patients. BMC Infect Dis 2007, 7:138.
11. Gourin S., Vabret A., Gault E., Petitjean J., Regeasse A., Hurault de Ligny B., et al. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay. J Clin Microbiol 2004, 29:194-201.
12. Gourin S., Vabret A., Scieux C., Agbalika F., Cherot J., Mengelle C., et al. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay. J Virol Methods 2007, 146:147-154.
13. Gracia-Ahufinger I., Tormo N., Espigado I., Solano C., Urbano-Ispizua A., Clari M.A., et al. Differences in cytomegalovirus plasma viral loads measured in allogeneic hematopoietic stem cell transplant recipients using two commercial real-time PCR assays. J Clin Microbiol 2010, 48:142-146.
14. Gimeno C., Solano C., Latorre J.C., Hernandez-Boluda J.C., Clari M.A., Remigia M.J., et al. Quantification of DNA in plasma by an automated real-time PCR assay (Cytomegalovirus PCR Kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allergenic hematopoietic stem cells transplant recipients. J Clin Microbiol 2008, 46(10):3311-3318.
15. Hernando S., Folgueira L., Lumbreras C., San Juan R., Maldonado S., Prieto C., et al. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. Transplant Proc 2005, 37:4094-4096.
16. Rhee J.Y., Peck K.R., Lee N.Y., Song J.H. Clinical usefulness of plasma quantitative polymerase chain reaction assay: diagnostic of cytomegalovirus infection in kidney transplant recipients. Transplant Proc 2011, 43:2624-2629.
17. Lugert R., Reichard U., Hufert F.T., Groß U. Comparison between pp65 antigenemia assay and quantitative real-time polymerase chain reaction for detection of active cytomegalovirus infection in routine diagnostics. Diagn Microbiol Infect Dis 2009, 65:192-195.
18. Piiparinen H., Höckerstedt K., Grönhagen-Riska C., Lautenschlager I. Comparison of two quantitative CMV PCR tests Cobas Amplicor CMV Monitor and Taqman assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol 2004, 30:258-266.
19. Gerna G., Lilleri D., Furione M., Baldanti F. Management of human cytomegalovirus infection in transplantation: validation of virologic cut-offs for preemptive therapy and immunological cut-offs for protection. New Microbiol 2011, 34(3):229-254.
20. Lilleri D., Lanzarotto T., Ghisetti V., Ravanini P., Capobianchi M.R., Baldanti F., et al. Transplant survelliance Group Multicenter quality control study for human cytomegalovirus DNAemia quantification. New Microbiol 2009, 32(3):245-253.
21. Sanghavi S.K., Abu-Elmagd K., Keightley M.C., St.George K., Lewandowski K., Boes S.S., et al. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. J Clin Virol 2008, 42:335-342.
22. Martin-Davila P., Fortun J., Gutierrez C., Marti-Belda P., Candelas A., Honrubia A., et al. Analysis of quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J Clin Virol 2005, 33:138-144.
23. Pang X.L., Fox J.D., Fenton J.M., Miller G.G., Caliendo A.M. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 2009, 9:258-268.
24. Kraft C.S., Armstrong W.S., Caliendo A.M. Interpreting quantitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin Infect Dis 2012, 54(12):1793-1797.
25. Lisboa L.F., Asberg A., Kumar D., Pang X., Hartmann A., Preiksaitis J.K., et al. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011, 91(2):231-236.
26. Emery V.C., Sabin C.A., Cope A.V., Gor D., Hassan-Walker A.F., Griffiths P.D. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000, 355:2032-2036.